Caelum Biosciences' Debt Round

Caelum Biosciences raised a round of funding on August 11, 2017.

Caelum Biosciences, a Fortress Biotech Company (NASDAQ: FBIO), is a clinical stage biotechnology company developing treatments for rare and life-threatening conditions. Caelum's lead asset, CAEL-101, …

Articles about Caelum Biosciences' Debt Round: